-
1.PROTEIN MODIFICATION FROM THE OXIDATION OF CLICKABLE POLYUNSATURATED FATTY ACID ANALOGS 审中-公开
Title translation: 蛋白质从可氧化的多不饱和脂肪酸类似物的氧化改变公开(公告)号:WO2011079188A2
公开(公告)日:2011-06-30
申请号:PCT/US2010/061768
申请日:2010-12-22
Applicant: LIFE TECHNOLOGIES CORPORATION , AGNEW, Brian , PICKENS, Chad , SINGH, Upinder
Inventor: AGNEW, Brian , PICKENS, Chad , SINGH, Upinder
IPC: C07C247/08 , C07C233/09 , G01N33/68
CPC classification number: C07C247/04 , C07C233/09 , G01N33/5008 , G01N33/5308 , G01N33/68 , G01N33/6842 , G01N2440/00 , G01N2440/12
Abstract: Clickable polyunsaturated fatty acid analogs, methods of using these analogs and kits comprising these analogs.
Abstract translation: 可点击的多不饱和脂肪酸类似物,使用这些类似物的方法和包含这些类似物的试剂盒。 p>
-
2.PROTEIN MODIFICATION FROM THE OXIDATION OF CLICKABLE POLYUNSATURATED FATTY ACID ANALOGS 审中-公开
Title translation: 从点燃多糖脂肪酸类似物氧化中的蛋白质修饰公开(公告)号:WO2011079188A3
公开(公告)日:2011-11-17
申请号:PCT/US2010061768
申请日:2010-12-22
Applicant: LIFE TECHNOLOGIES CORP , AGNEW BRIAN , PICKENS CHAD , SINGH UPINDER
Inventor: AGNEW BRIAN , PICKENS CHAD , SINGH UPINDER
IPC: C07C247/08 , C07C233/09 , G01N33/68
CPC classification number: C07C247/04 , C07C233/09 , G01N33/5008 , G01N33/5308 , G01N33/68 , G01N33/6842 , G01N2440/00 , G01N2440/12
Abstract: Clickable polyunsaturated fatty acid analogs, methods of using these analogs and kits comprising these analogs.
Abstract translation: 可点击的多不饱和脂肪酸类似物,使用这些类似物的方法和包含这些类似物的试剂盒。
-
公开(公告)号:WO2012054831A3
公开(公告)日:2012-06-07
申请号:PCT/US2011057284
申请日:2011-10-21
Applicant: RTU PHARMACEUTICALS LLC , PERGOLIZZI JOSEPH , MIRONOV ALEXANDER , PICKENS CHAD JAMES , JOHNSON DOUGLAS GILES
Inventor: PERGOLIZZI JOSEPH , MIRONOV ALEXANDER , PICKENS CHAD JAMES , JOHNSON DOUGLAS GILES
CPC classification number: A61K31/407 , A61K9/0019 , A61K9/08 , A61K47/26
Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
Abstract translation: 在某些实施方案中公开了一种用于肠胃外给药的药物组合物,其包含:包含量为约0.1mg / mL至约10mg / mL的酮咯酸或其药学上可接受的盐的水溶液; 和药学上可接受的赋形剂; 其中该制剂基本上不含醇。
-
公开(公告)号:WO2012054831A2
公开(公告)日:2012-04-26
申请号:PCT/US2011/057284
申请日:2011-10-21
Applicant: RTU PHARMACEUTICALS, LLC , PERGOLIZZI, Joseph , MIRONOV, Alexander , PICKENS, Chad, James , JOHNSON, Douglas, Giles
IPC: A61K31/407 , A61P29/00
CPC classification number: A61K31/407 , A61K9/0019 , A61K9/08 , A61K47/26
Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.
Abstract translation: 在某些实施方案中公开的是用于肠胃外给药的药物组合物,其包含:包含约0.1mg / mL至约10mg / mL的量的酮咯酸或其药学上可接受的盐的水溶液; 和药学上可接受的赋形剂; 其中所述制剂基本上不含醇。
-
-
-